At Mundipharma Research, we are passionate about working in partnership with others to develop innovative medicines for patients with high unmet needs around the world.
From our base in Cambridge in the UK, our experienced in-house teams apply their expertise to progress early innovations through their entire development – from investigational new drug (IND) submission through to reimbursement.
Being part of the Mundipharma global network of privately-owned independent associated companies enables us to take the long view as we build lasting partnerships with others to develop future medicines in pain and other therapeutic areas.
For information about oncology development within the Mundipharma network, please also visit edoncology.com.
Press return to search